1,408 articles

First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

in Cancer Immunity and Immunotherapy

• Toshio Shimizu
• John Powderly
• Albiruni Abdul Razak
• Patricia LoRusso
• Kathy D. Miller
• Steven Kao
• Sarah Kongpachith
• Catherine Tribouley
• Michelle Graham
• Brian Stoll

Case report: Immune checkpoint inhibitor-induced paraneoplastic neurological syndrome in two patients: a case series

in Cancer Immunity and Immunotherapy

• Guang-Qing Shi
• Heng-Ning Lian
• Huan Wang
• Jie-Qiang Xia
• Li-Jie Ma
• Jing Zhou

Prognostic significance of systemic pan-immune-inflammation value in locally advanced cervical cancer

in Cancer Immunity and Immunotherapy

• Shu Yan
• Xin Gong
• Rui Liu
• Xiaojing Jia

Tislelizumab plus chemotherapy in metastatic extramammary Paget disease after surgery: a case report

in Cancer Immunity and Immunotherapy

• Dongxing Wang
• Chuang Huang
• Dongming Wang

Personalized three-year survival prediction and prognosis forecast by interpretable machine learning for pancreatic cancer patients: a population-based study and an external validation

in Cancer Immunity and Immunotherapy

• Buwei Teng
• Xiaofeng Zhang
• Mingshu Ge
• Miao Miao

Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma

in Cancer Immunity and Immunotherapy

• Ryan A. Lacinski
• Sebastian A. Dziadowicz
• Clark A. Roth
• Li Ma
• Vincent K. Melemai
• Brody Fitzpatrick
• Edwin Chaharbakhshi
• Tanya Heim
• Ines Lohse
• Karen E. Schoedel

Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review

in Cancer Immunity and Immunotherapy

• Wenwen Kang
• Jing Cheng
• Luyun Pan
• Ping Zhan
• Hongbing Liu
• Tangfeng Lv
• Hedong Han
• Yong Song

Retraction: Mir-124 attenuates STAT3-mediated TH17 differentiation in colitis-driven colon cancer

in Cancer Immunity and Immunotherapy

Retrospective analysis of survival and safety of bevacizumab biosimilar and original drug combination chemotherapy in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

• Xinyi Zhang
• Xiaofei Chu
• Jun Wang
• Wenjing Gu
• Xiaoyan Fu
• Jing Zhang
• Congying Wang
• Qinghui Han
• Jing Zhou
• Yongjing Zhang

Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids

in Cancer Immunity and Immunotherapy

• Neta Bar-Hai
• Rakefet Ben-Yishay
• Sheli Arbili-Yarhi
• Naama Herman
• Vered Avidan-Noy
• Tehillah Menes
• Aiham Mansour
• Fahim Awwad
• Nora Balint-Lahat
• Gil Goldinger

Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report

in Cancer Immunity and Immunotherapy

• Monica Mariniello
• Giulia Arrivi
• Laura Tufano
• Antonio Lauletta
• Mirella Moro
• Giacomo Tini
• Matteo Garibaldi
• Raffaele Giusti
• Federica Mazzuca

Innovative strategies in genitourinary cancer: the role of oncolytic viruses

in Cancer Immunity and Immunotherapy

• Jie Zhang
• Kepu Liu
• Zheng Zhu
• Shihao Shang
• Di Wei
• Yu Zheng
• Lei Zhang
• Ying Liang
• Dongen Ju
• Jianlin Yuan

IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer

in Cancer Immunity and Immunotherapy

• Lina Somri-Gannam
• Shilhav Meisel-Sharon
• Shay Hantisteanu
• Tomer Bar-Noy
• Emiliya Sigal
• Gabriel Groisman
• Mordechai Hallak
• Haim Werner
• Ilan Bruchim

Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy

in Cancer Immunity and Immunotherapy

• Nahum Puebla-Osorio
• Natalie Wall Fowlkes
• Hampartsoum B. Barsoumian
• Kristina Xega
• Gitika Srivastava
• Claudia Kettlun-Leyton
• Sara Nizzero
• Tiffany Voss
• Thomas S. Riad
• Christina Wong

FAS gene expression, prognostic significance and molecular interactions in lung cancer

in Cancer Immunity and Immunotherapy

• Kaimin Li
• Shing Cheng Tan
• Zhihao Yang

Case report: Fatal hemoptysis after effective treatment with tislelizumab and anlotinib in pulmonary sarcomatoid carcinoma

in Cancer Immunity and Immunotherapy

• Chen-Wei Pu
• Yong-Fen Ma
• Jing-Jing Peng
• Zhen-Zhen Wang